Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00480Lenalidomide1 / 2Completed1
DB08935Obinutuzumab1 / 2Completed1